Skip to main content
. 2022 May 22;14(10):2552. doi: 10.3390/cancers14102552

Figure 2.

Figure 2

Figure 2

Cumulative disease-specific survival in primary small bowel neuroendocrine tumors stratified by (A) MCT1 score, (B) MCT4 staining intensity, (C) MCT4 percentage of positive cells, and (D) MCT4 score.